Fentonium bromide

Fentonium bromide
Clinical data
ATC code
Pharmacokinetic data
Bioavailability1
Identifiers
  • [8-Methyl-8-[2-oxo-2-(4-phenylphenyl)ethyl]-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate bromide
CAS Number
PubChem CID
DrugBank
UNII
ECHA InfoCard100.025.018 Edit this at Wikidata
Chemical and physical data
FormulaC31H34BrNO4
Molar mass564.520 g·mol−1
 ☒NcheckY (what is this?)  (verify)

Fentonium bromide (INN) is an anticholinergic and antispasmodic atropine derivative.[1] In the US its patent number is 3,356,682.[2] It is sold by Sanofi-Aventis and Zambon.[3]

  1. ^ Milne GW (2002). "Fentonium bromide". Drugs: Synonyms and Properties (2nd ed.). Aldershot, Hampshire, England: Ashgate. p. 2785. ISBN 978-0-566-08491-1.
  2. ^ "Fentonium". DrugBank. 17 August 2016. Retrieved 19 December 2016.
  3. ^ "Ulcesium (fentonium bromide) drug & pharmaceuticals. Ulcesium available forms, doses, prices". sdrugs.com. Retrieved 19 December 2016.